2024 Europe Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations
The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
I. Introduction
II. Hepatitis Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 CLASSIFICATION
0 TRANSMISSION OF INFECTION
0 OCCUPATIONAL HAZARDS
0 ACUTE HEPATITIS
0 DIAGNOSIS OF ACUTE INFECTION
0 CHRONIC HEPATITIS
0 HCV AND OTHER CHRONIC LIVER DISEASES
0 ALCOHOLIC LIVER DISEASE
0 HEPATITIS B COINFECTION
0 CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
0 DIAGNOSTIC TESTS
0 POSSIBLE INDICATIONS FOR HCV RNA TESTING
0 CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
0 HISTORICAL PERSPECTIVE
0 EPIDEMIOLOGY
0 HBV-HDV COINFECTION" VS. "SUPERINFECTION
"
II. Hepatitis Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 CLASSIFICATION
0 TRANSMISSION OF INFECTION
0 OCCUPATIONAL HAZARDS
0 ACUTE HEPATITIS
0 DIAGNOSIS OF ACUTE INFECTION
0 CHRONIC HEPATITIS
0 HCV AND OTHER CHRONIC LIVER DISEASES
0 ALCOHOLIC LIVER DISEASE
0 HEPATITIS B COINFECTION
0 CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
0 DIAGNOSTIC TESTS
0 POSSIBLE INDICATIONS FOR HCV RNA TESTING
0 CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
0 HISTORICAL PERSPECTIVE
0 EPIDEMIOLOGY
0 HBV-HDV COINFECTION" VS. "SUPERINFECTION
"